# FDA Inspection 1112312 - Scendia Biologics, LLC - November 13, 2019

Source: https://www.keypedia.com/records/fda_inspections/scendia-biologics-llc/d93f4e40-a512-4786-9dc1-2b8a68f967d1
Source feed: FDA_Inspections

> FDA Inspection 1112312 for Scendia Biologics, LLC on November 13, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1112312
- Company Name: Scendia Biologics, LLC
- Inspection Date: 2019-11-13
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1226358 - 2023-12-19](https://www.keypedia.com/records/fda_inspections/scendia-biologics-llc/238c388b-6abe-41ba-9e86-27fceec7fad0)
- [FDA Inspection 1028500 - 2017-07-31](https://www.keypedia.com/records/fda_inspections/scendia-biologics-llc/e327758d-93e1-4694-b290-8bef30405797)

Company: https://www.keypedia.com/companies/scendia-biologics-llc/c20616ed-5da1-472f-958d-f429e4b1fa10

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d